It mean that our eligible R&D Expenditure will be 10 mil,
ECT will get refound of 45% which is $4.5 mil
10 mil will come from Brevet to pay for our share of the plant
We will need only $ 5.5 mil from options conversion or revenues, royalties or licensing fees to repay this loan
Plus R&D from Matmor !
Ann: Half Year Accounts, page-36
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ECT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(20.0%) |
Mkt cap ! $6.343M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $4 | 2.168K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 31335663 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 14672053 | 29 |
View Market Depth
| Last trade - 12.58pm 27/09/2024 (20 minute delay) ? |
| ECT (ASX) Chart |